TY  - GEN
AU  - Jacobs,Maartje S
AU  - de Jong,Lisa A
AU  - Postma,Maarten J
AU  - Tieleman,Robert G
AU  - van Hulst,Marinus
TI  - Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation
SN  - 1618-7601
PY  - 2018///0827
KW  - Atrial Fibrillation
KW  - therapy
KW  - Cost-Benefit Analysis
KW  - Electric Countershock
KW  - Factor Xa Inhibitors
KW  - economics
KW  - Humans
KW  - Netherlands
KW  - Quality of Life
KW  - Quality-Adjusted Life Years
KW  - Rivaroxaban
KW  - Stroke
KW  - prevention & control
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1007/s10198-017-0942-2
ER  -